Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This synthetic peptide mimics the actions of naturally produced GLP-1, a https://barryclrw134875.arwebo.com/61457217/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes